Metabolic profiling used for development of new diabetes therapies.

被引：0
|
作者：
Newgard, CB [1 ]
机构：
[1] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
来源：
BIOCHEMISTRY | 2003年 / 42卷 / 28期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
16
引用
收藏
页码：8597 / 8597
页数：1
相关论文
共 50 条
  • [41] Evaluation of the sensory system in a commonly used contusive spinal cord injury model for assessment of regenerative cellular therapies.
    Berrocal, YA
    Pearse, DD
    Andrade, CM
    Gomez-Marin, O
    Bunge, MB
    Eaton, MJ
    EXPERIMENTAL NEUROLOGY, 2004, 187 (01) : 204 - 204
  • [42] Bringing the evidence to practice: Development of guidelines for mucositis prevention and management in patients receiving cancer therapies.
    Dunne, M
    Kelvin, J
    Derby, S
    Montefusco, M
    Cawley, K
    Lucas, J
    Gilman, J
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 396 - 397
  • [43] ESTRADIOL IS ASSOCIATED WITH DECREASED CARDIOVASCULAR RISK COMPARED TO ETHINYLESTRADIOL WHEN CONTAINED IN COMBINED HORMONAL PREPARATIONS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW ENDOMETRIOSIS THERAPIES.
    von Stockum, Sophia
    Barnett, Clare
    Bauerfeind, Anja
    Heinemann, Klaas
    FERTILITY AND STERILITY, 2020, 114 (03) : E78 - E79
  • [44] Exenatide and pramlintide: new therapies for diabetes
    Want, L. L.
    Ratner, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (12) : 1522 - 1523
  • [45] New technologies and therapies in the management of diabetes
    Triplitt, Curtis L.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (02): : S47 - S54
  • [46] METASNCore: A new tool for palliative whole brain radiotherapy (WBRT) assessment in the era of targeted therapies.
    Flores Paco, Pablo
    Vargas, Alicia
    Geraldina Guevara, Maria
    Lopera, Ignacio
    Rodriguez Ruiz, Lucia
    Maria, Lopez-Herrero
    Adrian Camus, Juan
    Lopez-Gonzalez, Javier
    Inga-Saavedra, Elizabeth
    Montero, Marina
    Barneto, Isidoro
    Auxiliadora Gomez, Maria
    Ruiz, Estela
    Ruza, Marta
    Luz Tudela, Maria
    Palacios, Amalia
    De La Haba, Juan
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom
    Sterzi, Daniel
    Auziere, Sebastien
    Glah, Diuina
    Jensen, Marie Markert
    PRIMARY CARE DIABETES, 2017, 11 (03) : 241 - 247
  • [48] Advanced cell culture technology has been key to the rapid development of cellular, gene, and tissue therapies.
    Lages, A
    Swartz, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U171 - U171
  • [49] Emerging therapies for metabolic diseases-the focus is on diabetes and obesity
    Hughes, Thomas E.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2009, 13 (03) : 332 - 337
  • [50] Diabetes and ischaemic heart disease: essential role for metabolic therapies
    Stanley, WC
    CORONARY ARTERY DISEASE, 2005, 16 : S1 - S1
12345